IntriCon Co. (NASDAQ:IIN) has been assigned a consensus recommendation of “Buy” from the seven ratings firms that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $54.00.
IIN has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of Vistra Energy from a “hold” rating to a “buy” rating and set a $25.00 target price for the company in a research note on Saturday. ValuEngine lowered shares of Whiting USA Trust II from a “hold” rating to a “sell” rating in a research note on Tuesday, May 7th.
Shares of IntriCon stock traded up $0.34 during trading on Wednesday, reaching $21.18. 126,654 shares of the company traded hands, compared to its average volume of 106,781. The company has a quick ratio of 2.23, a current ratio of 3.13 and a debt-to-equity ratio of 0.04. IntriCon has a 1-year low of $20.41 and a 1-year high of $76.80. The company has a 50 day moving average price of $24.05. The company has a market cap of $182.08 million, a price-to-earnings ratio of 33.09, a PEG ratio of 2.98 and a beta of 0.78.
IntriCon (NASDAQ:IIN) last released its earnings results on Monday, April 29th. The technology company reported $0.08 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.10 by ($0.02). The company had revenue of $30.11 million for the quarter, compared to analyst estimates of $30.05 million. IntriCon had a net margin of 4.58% and a return on equity of 7.39%. As a group, equities research analysts forecast that IntriCon will post 0.58 earnings per share for the current year.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Emerald Mutual Fund Advisers Trust purchased a new position in shares of IntriCon in the 1st quarter worth about $4,399,000. Ranger Investment Management L.P. purchased a new position in shares of IntriCon in the 4th quarter worth about $2,676,000. Marshall Wace LLP boosted its holdings in shares of IntriCon by 51.4% in the 1st quarter. Marshall Wace LLP now owns 244,688 shares of the technology company’s stock worth $6,137,000 after buying an additional 83,103 shares during the last quarter. Kennedy Capital Management Inc. purchased a new position in shares of IntriCon in the 1st quarter worth about $1,697,000. Finally, Two Sigma Investments LP purchased a new position in shares of IntriCon in the 4th quarter worth about $1,616,000. Hedge funds and other institutional investors own 72.51% of the company’s stock.
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
Featured Story: What is Cost of Capital?
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.